Literature DB >> 11017923

Post-transcriptional deregulation of myc genes in lung cancer cell lines.

N L Bernasconi1, T A Wormhoudt, I A Laird-Offringa.   

Abstract

Genes of the myc family are frequently overexpressed in lung cancer. Gene amplification can explain the deregulation of these genes in a subset of tumors and cell lines, but in most cases, the cause of the elevated myc expression remains unknown. We examined whether messenger RNA (mRNA) stabilization could be contributing to myc gene overexpression in lung cancer cell lines. The decay pattern of c-myc or N-myc mRNA was analyzed in 11 such cell lines and in unimmortalized human embryonic lung cells. Eight lung cancer cell lines showed stabilization of c-myc or N-myc transcripts. To determine whether this stabilization was unique to myc genes, the decay pattern of the unstable c-fos proto-oncogene mRNA was also studied. The same cell lines that exhibited stabilization of myc mRNA showed an abnormally slow decay of the c-fos message, suggesting that there might be a correlation between the abnormal decay of c-fos and myc transcripts. In contrast, the half-life of histone 2B mRNA, which is degraded in a cell cycle-specific manner, did not appear to correlate with that of myc and fos. Our results suggest that an mRNA decay pathway responsible for the destruction of unstable proto-oncogene mRNAs may be commonly affected in lung cancers.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11017923     DOI: 10.1165/ajrcmb.23.4.4233

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  11 in total

1.  Genome-wide analysis of mRNA decay in resting and activated primary human T lymphocytes.

Authors:  Arvind Raghavan; Rachel L Ogilvie; Cavan Reilly; Michelle L Abelson; Shalini Raghavan; Jayprakash Vasdewani; Mitchell Krathwohl; Paul R Bohjanen
Journal:  Nucleic Acids Res       Date:  2002-12-15       Impact factor: 16.971

2.  Wnt pathway aberrations including autocrine Wnt activation occur at high frequency in human non-small-cell lung carcinoma.

Authors:  G Akiri; M M Cherian; S Vijayakumar; G Liu; A Bafico; S A Aaronson
Journal:  Oncogene       Date:  2009-04-20       Impact factor: 9.867

Review 3.  Processing body (P-body) and its mediators in cancer.

Authors:  Bernard Nsengimana; Faiz Ali Khan; Ebenezeri Erasto Ngowi; Xuefeng Zhou; Yu Jin; Yuting Jia; Wenqiang Wei; Shaoping Ji
Journal:  Mol Cell Biochem       Date:  2022-01-28       Impact factor: 3.396

Review 4.  Lung cancer. 9: Molecular biology of lung cancer: clinical implications.

Authors:  K M Fong; Y Sekido; A F Gazdar; J D Minna
Journal:  Thorax       Date:  2003-10       Impact factor: 9.139

Review 5.  Histopathological transformation to small-cell lung carcinoma in non-small cell lung carcinoma tumors.

Authors:  Rita Dorantes-Heredia; José Manuel Ruiz-Morales; Fernando Cano-García
Journal:  Transl Lung Cancer Res       Date:  2016-08

6.  Stabilization of hepatocyte growth factor mRNA by hypoxia-inducible factor 1.

Authors:  Sheng-Hua Chu; Dong-Fu Feng; Yan-Bin Ma; Zhi-An Zhu; Hong Zhang; Jian-Hua Qiu
Journal:  Mol Biol Rep       Date:  2008-11-02       Impact factor: 2.316

7.  Comprehensive in vivo identification of the c-Myc mRNA protein interactome using HyPR-MS.

Authors:  Michele Spiniello; Maisie I Steinbrink; Anthony J Cesnik; Rachel M Miller; Mark Scalf; Michael R Shortreed; Lloyd M Smith
Journal:  RNA       Date:  2019-07-11       Impact factor: 4.942

8.  Oesophageal adenocarcinoma is associated with a deregulation in the MYC/MAX/MAD network.

Authors:  J K R Boult; P Tanière; M T Hallissey; M J Campbell; C Tselepis
Journal:  Br J Cancer       Date:  2008-05-20       Impact factor: 7.640

9.  Linc-RoR promotes c-Myc expression through hnRNP I and AUF1.

Authors:  Jianguo Huang; Ali Zhang; Tsui-Ting Ho; Ziqiang Zhang; Nanjiang Zhou; Xianfeng Ding; Xu Zhang; Min Xu; Yin-Yuan Mo
Journal:  Nucleic Acids Res       Date:  2015-12-09       Impact factor: 16.971

Review 10.  Role of Pseudogenes in Tumorigenesis.

Authors:  Xinling Hu; Liu Yang; Yin-Yuan Mo
Journal:  Cancers (Basel)       Date:  2018-08-01       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.